Cook, NJ
Charles Cook, Mendham, NJ US
Patent application number | Description | Published |
---|---|---|
20090155846 | KINASE ANCHOR PROTEIN MUTEINS, PEPTIDES THEREOF AND RELATED METHODS - A-kinase anchor protein (AKAPS) muteins, peptides thereof, and nucleic acids encoding the peptides are provided herein. Also provided are transgenic animals, cells comprising transgenes and various methods employing such peptides. | 06-18-2009 |
Charles M. Cook, Mendham, NJ US
Patent application number | Description | Published |
---|---|---|
20090018141 | KINASE INHIBITORS, COMPOSITIONS THEREOF, AND METHODS OF USE THEREWITH - Provided herein are Compounds having the following structure: | 01-15-2009 |
20110217324 | INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF - Provided herein are novel compounds, pharmaceutical compositions containing such compounds and methods for their use. In particular, the compounds described herein are useful for the treatment or prevention of diseases associated with T cell proliferation such as autoimmune diseases and disorders. | 09-08-2011 |
Charles Michael Cook, Mendham, NJ US
Patent application number | Description | Published |
---|---|---|
20090111755 | METHODS FOR THE USE OF INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES - The present invention relates to compounds, pharmaceutical compositions containing such compounds and methods for their use. In particular, the compounds of the invention are useful for the treatment or prevention of diseases associated with T cell proliferation such as autoimmune diseases and disorders. | 04-30-2009 |
20090156624 | Methionine aminopeptidase-2 inhibitors and methods of use thereof - The present invention provides methods of parasitic infections, thymoma, and lymphoid malignancies in a subject by administering to the subject a therapeutically effective amount of one or more of the compounds of the invention. | 06-18-2009 |
20120252734 | INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES - The present invention relates to compounds, pharmaceutical compositions containing such compounds and methods for their use. In particular, the compounds of the invention are useful for the treatment or prevention of diseases associated with T cell proliferation such as autoimmune diseases and disorders. | 10-04-2012 |
Debra Cook, Tinton Falls, NJ US
Patent application number | Description | Published |
---|---|---|
20130036474 | Method and Apparatus for Secure Data Representation Allowing Efficient Collection, Search and Retrieval - A system and method for secure representation of data is presented. The method comprises setting a number of components, dividing original data into the set number of components using a function, storing the set number of components of divided data, determining a number of retrieved components, and using the function to retrieve the data from the retrieved components and to determine retrieved data. In one aspect, the function is XOR. In one aspect, when the number of retrieved components is less than the set number of components, the retrieved data is redacted data, and when the number of retrieved components is equal to the set number of components, the retrieved data is the original data. | 02-07-2013 |
Debra L. Cook, Tinton Falls, NJ US
Patent application number | Description | Published |
---|---|---|
20090064294 | Methods for selectively capturing and replicating one-time password generator functionality from device to device - Structures and methods are disclosed for selectively capturing (“peeling”) and replicating (“cloning”) OTP tokens from one device to another while maintaining OTP state. Embodiments described herein provide for sending, from a first device to a second device, state information including for example, a key, a current OTP sequence value and a time to expiry value corresponding to selected tokens to be cloned. The second device thereafter uses the state information to generate OTP sequences corresponding to the selected tokens in time-synchronization with corresponding authentication entities. Additionally, embodiments described herein provide for restoring the OTP sequence corresponding to the selected tokens on the first device following a loss of synchronization of the selected tokens on the first device. | 03-05-2009 |
20090089859 | Method and apparatus for detecting phishing attempts solicited by electronic mail - A phishing filter employs a plurality of heuristics or rules (in one embodiment, 12 rules) to detect and filter phishing attempts solicited by electronic mail. Generally, the rules fall within the following categories: (1) identification and analysis of the login URL (i.e., the “actual” URL) in the email, (2) analysis of the email headers, (3) analysis across URLs and images in the email other than the login URL, and (4) determining if the URL is accessible. The phishing filter does not need to be trained, does not rely on black or white lists and does not perform keyword analysis. The filter may be implemented as an alternative or supplemental to prior art spam detection filters. | 04-02-2009 |
20090125997 | Network node with one-time-password generator functionality - Structures and methods are disclosed for facilitating secure connectivity of a remote client to an enterprise network using OTP-enabled nodes of a remote access platform. Embodiments described herein include an OTP device associated with a client device (for example and without limitation, an OTP device residing within a PC card associated with a laptop or desktop computer) defining a first node of a remote access platform; and an OTP server defining a second node of a remote access platform that generates and maintains the same OTP as the OTP device at the first node, for purposes of authenticating the client device and/or user of the client device. | 05-14-2009 |
20090328165 | Method and apparatus for generating one-time passwords - A method and apparatus are provided to allow a user of a communications device to utilize one-time password generators for two-way authentication of users and servers, i.e., proving to users that servers are genuine and proving to servers that users are genuine. The present invention removes the need for a user to have a separate physical device, e.g., token, per company or service, reduces the cost burden on the companies and allows for two-way authentication via multiple access methods, e.g., telephone, web interfaces, automatic teller machines (ATMs), etc. Also, the present invention may be utilized in consumer and enterprise applications. | 12-31-2009 |
Debra Lee Cook, Tinton Falls, NJ US
Patent application number | Description | Published |
---|---|---|
20090034515 | Call Setup Request Confirmation - At least one exemplary embodiment of the present invention includes a method comprising receiving a call setup request, and automatically providing an indication that the call setup request is being processed. At least one exemplary embodiment of the present invention includes a method comprising providing a call setup request to a network, and receiving an indication that the call setup request is being processed. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. This abstract is submitted with the understanding that it will not be used to interpret or limit the scope. | 02-05-2009 |
Gary Cook, Plain City, NJ US
Patent application number | Description | Published |
---|---|---|
20110042387 | IMMERSION HEATERS - Disclosed is a heating unit which can comprise a tube, or pipe, having an aperture therein which can be configured to receive a heating element. In various embodiments, the heating element can comprise a resistive element which can be configured to generate heat when a voltage differential is applied thereto. In certain embodiments, the heating unit can further comprise a collar which is threadably engaged with the tube, wherein a flame path, or exhaust path, can be defined between threads on the pipe and threads on the collar, for example. In certain embodiments, the flame path can comprise a passageway defined between the circumference, or perimeter, of the tube and the collar. Such a flame path can be configured to allow pressurized gasses to safely escape from the tube along a predetermined path. | 02-24-2011 |
Geoffrey Cook, Pennington, NJ US
Patent application number | Description | Published |
---|---|---|
20130226696 | SOCIAL DISCOVERY SYSTEM USING COMPUTING DEVICE PROXIMITY - Technologies for providing a social discovery system enable a user to complement his or her real world activities with online services. For example, the user is associated with a computing device and a user context. A server connected to the computing device determines an offer for a service based on the computing device and the user context. The server may limit the acceptance of the offer to predefined real world physical conditions. The conditions may require the user to accept the offer while being located in proximity of a second user who has received a similar offer. The server receives from the computing device a request accepting the offer and demanding an activation of the service. The server compares the request to the conditions, authenticates the computing device, and activates the service. | 08-29-2013 |
Jane Cook, Mountain Lakes, NJ US
Patent application number | Description | Published |
---|---|---|
20100082384 | SYSTEMS AND METHODS FOR COMPREHENSIVE CONSUMER RELATIONSHIP MANAGEMENT - A comprehensive consumer relationship management system is disclosed. The comprehensive consumer relationship management system includes dispute resolution, customized data modeling, advertising assistance, and secure communications. By providing value added features, the comprehensive consumer relationship management system may strengthen consumer relationships by, for example, creating detailed data analysis to aid in making business decisions and facilitating secure communications among diverse consumers. | 04-01-2010 |
20140365357 | SYSTEMS AND METHODS FOR COMPREHENSIVE CONSUMER RELATIONSHIP MANAGEMENT - A comprehensive consumer relationship management system is disclosed. The comprehensive consumer relationship management system includes dispute resolution, customized data modeling, advertising assistance, and secure communications. By providing value added features, the comprehensive consumer relationship management system may strengthen consumer relationships by, for example, creating detailed data analysis to aid in making business decisions and facilitating secure communications among diverse consumers. | 12-11-2014 |
Jeffrey A. Cook, Lawrenceville, NJ US
Patent application number | Description | Published |
---|---|---|
20140031231 | FORMULATIONS OF CLOMAZONE - New formulations of clomazone are provided, as well as new methods for making formulations of clomazone. The new formulations provide improved efficacy, decreased volatility, and/or increased loading of clomazone over the clomazone formulations in the prior art. | 01-30-2014 |
Kane Cook, Morristown, NJ US
Patent application number | Description | Published |
---|---|---|
20120015863 | CLEANING COMPOSITIONS AND METHODS - The invention provides solvent and cleaning compositions comprising an ionic surfactant, which preferably has a fluorinated portion thereof, and a solvent selected from hydrofluoro- and/or hydrochlorofluoro-olefins. Additionally, the invention provides drying, dry cleaning, and soil repellency compositions containing a hydrofluoro- or hydrochlorofluoro-olefin and said surfactant. Additionally, the invention provides drying compositions containing a hydrofluoro-olefin or hydrochlorofluoro-olefin and an alcohol such as methanol, ethanol or isopropanol. | 01-19-2012 |
Kevin L. Cook, San Diego, NJ US
Patent application number | Description | Published |
---|---|---|
20090029927 | COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST SODIUM-DEPENDENT GLUCOSE TRANSPORTER - The invention is directed to compounds of the formula (I) described herein, a pharmaceutically acceptable salt thereof, or a prodrug thereof, and pharmaceutical compositions and methods of treatment. | 01-29-2009 |
Melvin Seymour Cook, Hohokus, NJ US
Patent application number | Description | Published |
---|---|---|
20100096404 | Liquid distribution - A method for expelling gas and distributing liquid from a container is disclosed. A piston on which an outlet is formed is positioned in a container holding gas and liquid. The piston and cylinder are so formed that movements of the piston can increase the pressure of the gas and the liquid. This pressure increase can be used to expel gas from the container via the piston outlet and to distribute liquid from the container via the piston outlet and/or another outlet. Expelling the gas minimizes degradation of liquid remaining in the container due to an interaction with the gas. | 04-22-2010 |
Mike Cook, Flemington, NJ US
Patent application number | Description | Published |
---|---|---|
20120066707 | SECURING PROPERTY - Methods, systems, and apparatuses for securing property are presented. Video content viewed by a user may be detected, and the user may be automatically prompted to change settings on a security system based on the detecting. A comparison of the current time with the duration of the video content may serve as the basis for such prompting. Additionally, a premise security system may be placed in a learning mode. Changes in position of a security sensor may be detected and used to set a permitted range of motion for the sensor. Further, a plurality of security sensor profiles may be stored, and each profile may identify a different predefined permitted range of motion of a sensor. The addition of a new sensor to a premise may be detected, and a user may be prompted, on a display, to identify a profile to be used for the new sensor. | 03-15-2012 |
Robert Cook, Hillsborough, NJ US
Patent application number | Description | Published |
---|---|---|
20110076334 | METHODS AND COMPOSITIONS FOR TREATMENT OF RAYNAUD'S PHENOMENON - Administration of a calcium channel blocker such as clevidipine or nicardipine in aerosol dry powder form directly to a patient's lungs for treating Raynaud's Phenomenon. | 03-31-2011 |
20110253133 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN - Administration of Oxybutynin directly to a patient's lungs for treating urinary incontinence, respiratory disease or IBD. | 10-20-2011 |
20130189319 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN - The present invention is directed to methods and compositions for treating pulmonary disease comprising delivering directly to a patient's lungs a therapeutically effective amount of oxybutynin in combination with one or more pharmaceutically effective agents. Oxybutynin may be selected from the group consisting of, but not limited to, a xinafoate salt, a palmitate salt, a pamoic salt, a resonate salt, a laurate salt and other salts. The pharmaceutically effective agents comprise bronchodilators, antiinflammatories, corticosteroids, corticosteroid reversal agent or alveolar growth agents or other agents selected from proteinase or protease inhibitors. | 07-25-2013 |
20130267593 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN - Administration of Oxybutynin directly to a patient's lungs for treating urinary incontinence, respiratory disease or IBD. | 10-10-2013 |
Robert O. Cook, Hillsborough, NJ US
Patent application number | Description | Published |
---|---|---|
20100081663 | METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE - Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed comprising: dampening the peak plasma concentration (C | 04-01-2010 |
20100081664 | METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE - Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed comprising: dampening the peak plasma concentration (C | 04-01-2010 |
20100183725 | MULTIPLE ACTIVE PHARMACEUTICAL INGREDIENTS COMBINED IN DISCRETE INHALATION PARTICLES AND FORMULATIONS THEREOF - The present disclosure describe inhalation particles where each discrete unagglomerated inhalation particle comprising 2 or more active pharmaceutical ingredients. In one embodiment, the inhalation particles comprise a first and a second API where the second API covers, at least partially, and protects the first API from degradation or instability. Inhalation particles comprising a first and a second API as described herein have many advantages over present means of delivering two or more APIs. Formulations comprising such inhalation particles are also described. | 07-22-2010 |
20100196286 | INHALATION DELIVERY METHODS AND DEVICES - Methods, devices and kits for treating sleep disorders, anxiety disorders, and developmental disorders, and/or for inducing an arousable state of sedation in a subject, are described. For example, inhalation methods, devices and kits for treating insomnia, anxiety and/or ADHD using one or more α2-adrenergic agonists such as dexmedetomidine or clonidine are described. | 08-05-2010 |
20100284940 | METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE - Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed comprising: dampening the peak plasma concentration (C | 11-11-2010 |
20110152280 | NOVEL ERGOLINE ANALOGS - Provided herein are novel ergoline derivatives and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 06-23-2011 |
20120077786 | METHODS AND COMPOSITIONS FOR DISEASE TREATMENT USING INHALATION - Methods and compositions for the treatment of pulmonary disease using inhalation are provided. In particular, the present disclosure provides novel methods and compositions for treating pulmonary diseases such as asthma, bronchitis, COPD, emphysema, lung cancer, pneumonia and pulmonary edema. In addition, the present disclosure provides novel methods and compositions for treating complications associated with pulmonary disease such as corticosteroid resistance and pulmonary tissue destruction. The compositions of the present disclosure comprise corticosteroid resistance agents including but not limited to vitamin D, calcitriol and equivalents thereof. The compositions of the present disclosure also comprise alveolar development and maintenance agents including but not limited to vitamin A, ATRA and equivalents thereof. The present invention provides effective administration of therapeutic agents to specific airways of the lungs by utilizing controlled site delivery. | 03-29-2012 |
20120245179 | Method Of Therapeutic Administration of DHE To Enable Rapid Relief Of Migraine While Minimizing Side Effect Profile - Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed comprising: dampening the peak plasma concentration (C | 09-27-2012 |
20120329806 | NOVEL FLUOROERGOLINE ANALOGS - Provided herein are novel fluoroergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 12-27-2012 |
20130158064 | NOVEL ISO-ERGOLINE DERIVATIVES - Provided herein are novel iso-ergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 06-20-2013 |
20130165469 | NOVEL NEUROMODULATORY COMPOUNDS - Provided herein are novel neuromodulatory compounds and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine and Parkinson's disease, using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 06-27-2013 |
20140005239 | Compositions and Methods for Treating or Preventing Pneumovirus Infection and Associated Diseases | 01-02-2014 |
20140039188 | NOVEL ISO-ERGOLINE DERIVATIVES - Provided herein are novel iso-ergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 02-06-2014 |
20140066450 | NOVEL FLUOROERGOLINE ANALOGS - Provided herein are novel fluoroergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 03-06-2014 |
20140073647 | NOVEL FLUOROERGOLINE ANALOGS - Provided herein are novel fluoroergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 03-13-2014 |
20140073790 | NOVEL FLUOROERGOLINE ANALOGS - Provided herein are novel fluoroergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 03-13-2014 |
20140094483 | NOVEL ISO-ERGOLINE DERIVATIVES - Provided herein are novel iso-ergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 04-03-2014 |
20140194434 | NOVEL SUBSTITUTED INDOLO 4,3 FG QUINOLINES USEFUL FOR TREATING MIGRAINE - Provided herein are novel ergoline derivatives and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 07-10-2014 |
20140194435 | NOVEL SUBSTITUTED INDOLO 4,3 FG QUINOLINES USEFUL FOR TREATING MIGRAINE - Provided herein are novel ergoline derivatives and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT | 07-10-2014 |
20150023888 | Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine - The invention is drawn to a novel, early interventional use of a pharmaceutical composition wherein administration of said pharmaceutical composition pre-empts the onset of migraine headaches, preferably anytime in the migraine cycle prior to pain onset. The pharmaceutical composition preferably is administered via inhalation in order to provide therapy to the subject in a timely fashion, ideally in a non-clinical setting. The pharmaceutical composition may also be administered to a subject at risk for stroke. | 01-22-2015 |
20150057287 | METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE - Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed comprising: dampening the peak plasma concentration (C | 02-26-2015 |
Robert Owen Cook, Hillsborough, NJ US
Patent application number | Description | Published |
---|---|---|
20100192945 | Inhalation devices and related methods for administration of sedative hypnotic compounds - An inhalation device for administering one or more sedatives via pulmonary delivery for treating a sleep disturbance. | 08-05-2010 |
20100236547 | Container for aerosol drug delivery - A metered does inhaler which includes a canister assembly which has a minimal volume canister and primeless valve to reduce waste, minimize total drug contained therein, and increase the reproducibility of dosage delivered. | 09-23-2010 |
20100291221 | Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation - Disclosed are methods, and related compositions, that include administering a dose-sparing amount of a formulation that includes inhalation particles to a subject by inhalation; wherein the inhalation particles comprise formoterol fumarate and budesonide, the formoterol fumarate and budesonide being in a distributed encapsulated morphology with respect to one another within said inhalation particles and the formoterol fumarate being in a predetermined mass ratio with regard to the budesonide within said inhalation particles. | 11-18-2010 |
20100319694 | Delivery of powdered drug via inhalation - Described herein are hand-held inhalation devices for use with tidal breathing that deliver powdered active agents to the respiratory system. The inhalation devices deliver a unit dose of the powdered active agent over a series of inhalations during tidal breathing. Methods for using the inhalation devices and kits for inhalation delivery of various active agents are also described. | 12-23-2010 |
20110082150 | Headache pre-emption by dihydroergotamine treatment during headache Precursor events - Disclosed are methods that address providing a subject experiencing, or who has experienced, a headache precursor event and administering dihydroergotamine, or a pharmaceutically acceptable salt or complex thereof, to the subject by oral inhalation, in an amount effective to pre-empt a subsequent headache in the subject. Also disclosed are compositions that are related to those methods. | 04-07-2011 |
20140023595 | INHALATION DEVICES AND RELATED METHODS FOR ADMINISTRATION OF SEDATIVE HYPNOTIC COMPOUNDS - An inhalation device for administering one or more sedatives via pulmonary inhalation for treating a sleep disturbance. | 01-23-2014 |
Thomas B. Cook, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20090140755 | Circuit board testing system - System including backplane, and first and second circuit boards. First circuit board is attached to backplane and has first optical signal transmitter. Second circuit board is attached to backplane and has first optical signal receiver. First optical signal transmitter and first optical signal receiver are mutually configured and mutually aligned for circuit board test signal communication from first circuit board to second circuit board across free space. Method includes providing backplane and first and second circuit boards, where first circuit board has first optical signal transmitter and second circuit board has first optical signal receiver. Method further includes attaching first and second circuit boards to backplane, and mutually configuring and mutually aligning first optical signal transmitter and first optical signal receiver for circuit board test signal communication from first circuit board to second circuit board across free space. | 06-04-2009 |